MARKET

BIOL

BIOL

BIOLASE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9631
-0.0019
-0.20%
After Hours: 1.020 +0.057 +5.91% 19:58 01/20 EST
OPEN
0.9753
PREV CLOSE
0.9650
HIGH
1.130
LOW
0.9523
VOLUME
56.21M
TURNOVER
--
52 WEEK HIGH
1.380
52 WEEK LOW
0.2110
MARKET CAP
90.06M
P/E (TTM)
-1.9136
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Dental Laser Market Outlook To 2025 | 3 Emerging Trends in APAC to drive the regional landscape
Jan 20, 2021 (Market Insight Reports) -- Asia Pacific dental laser market held nearly 22% revenue share in 2018 and due to the availability of improved...
Market Insight Reports · 10h ago
Thinking about buying stock in Caladrius Biosciences, Nio, Biolase, FuelCell Energy, or Carnival Corp?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLBS, NIO, BIOL, FCEL, and CCL.
PR Newswire - PRF · 13h ago
Dental Device Market Share 2021 Market Segmentation, Growth, Production by Manufacturers, Trends, Size, Regions and Forecast to 2025
Jan 20, 2021 (The Expresswire) -- “Final Report will add the analysis of the impact of COVID-19 on this industry” Global “Dental Device Market” research...
The Express Wire · 20h ago
Medical Laser Market Size, Share, Growth By Top Company, Region, Applications, Drivers, Trends & Forecast to 2025
Japan, Japan, Wed, 20 Jan 2021 02:48:45 / Comserve Inc. / -- The report offers overview of leading companies encompassing their successful marketing...
Comserve · 21h ago
5 Penny Stocks Riding The Biotech Wave In January 2021
Jan 19, 2021 (Penny Stocks via COMTEX) -- Biotech Penny Stocks To Watch This Week If you have been looking at the biotech industry, you've likely stumbled...
Penny Stocks · 1d ago
Hypodontia Market Size to Represent 6.2% CAGR By 2023
Heraldkeepers · 2d ago
The impact of COVID-19 on Dental Device Market Emerging Trends, Application Scope, Size, Status, Analysis And Forecast To 2026
Jan 15, 2021 (The Expresswire) -- The latest report as Dental Device Market acknowledges Size, Application Segment, Type, Regional Outlook, Market Demand,...
The Express Wire · 5d ago
Thinking about buying stock in Sundial Growers, FuelCell Energy, Nokia, BioNano Genomics, or Biolase?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, FCEL, NOK, BNGO, and BIOL.
PR Newswire - PRF · 6d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BIOL. Analyze the recent business situations of BIOLASE through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BIOL stock price target is 1.413 with a high estimate of 2.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 45
Institutional Holdings: 5.32M
% Owned: 5.69%
Shares Outstanding: 93.51M
TypeInstitutionsShares
Increased
7
452.19K
New
9
-141.08K
Decreased
8
584.90K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.34%
Healthcare Equipment & Supplies
+1.22%
Key Executives
Chairman/Independent Director
Jonathan Lord
President/Chief Executive Officer/Director
Todd Norbe
Chief Financial Officer/Executive Vice President
John Beaver
Vice President - Operations
Richard Whipp
Independent Director
Michael DiTolla
Independent Director
Richard Lanman
Independent Director
Jess Roper
Independent Director
Garrett Sato
Independent Director
Elaine Wagner
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.01
06/24/2005
--
Dividend USD 0.01
04/21/2005
--
Dividend USD 0.01
02/08/2005
--
Dividend USD 0.01
12/13/2004
--
Dividend USD 0.01
10/08/2004
07/27/2004
Dividend USD 0.01
08/12/2004
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BIOL
BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.
More

Webull offers kinds of BIOLASE Inc stock information, including NASDAQ:BIOL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIOL stock methods without spending real money on the virtual paper trading platform.